Company

About

Aignostics

Aignostics

Berlin, Germany

Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.

XO Life

XO Life

Agnes-Pockels-Bogen 1, Munich, Bavaria 80992, DE

XO Life stands for - a state-of-the-art platform solution for long-term Patient Insights from the real world - real time information exchange between patients and pharma - all-in-one platform to be used across all treatments and indications We are a young and dynamic eHealth company setting a new standard patient data collection through scientifically based questionnaires across all treatments and medications. XO Life helps the pharmaceutical industry to better understand its patients. Our goal is to make digital treatment monitoring and patient feedback the gold standard in R&D, marketing and sales, while ensuring the highest data protection and security standards.